These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6607392)

  • 1. Central antidopaminergic properties of 2-bromolisuride, an analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Kehr W; Sauer G
    Life Sci; 1983 Dec; 33(26):2583-97. PubMed ID: 6607392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdihydrolisuride, a partial dopamine receptor antagonist: effects on monoamine metabolism.
    Kehr W
    Eur J Pharmacol; 1984 Jan; 97(1-2):111-9. PubMed ID: 6421606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual action on central dopamine function of transdihydrolisuride, a 9, 10-dihydrogenated analogue of the ergot dopamine agonist lisuride.
    Wachtel H; Dorow R
    Life Sci; 1983 Jan; 32(4):421-32. PubMed ID: 6827903
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
    Wachtel H; Dorow R; Sauer G
    Life Sci; 1984 Oct; 35(18):1859-67. PubMed ID: 6492995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Bromolisuride, an ergot derivative, with dopamine antagonistic and serotonin agonistic properties.
    Fink H; Morgenstern R; Ott T
    Pharmacol Biochem Behav; 1991 Feb; 38(2):321-5. PubMed ID: 1905409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anorectic effect of lisuride and other ergot derivatives in the rat.
    Carruba MO; Ricciardi S; Müller EE; Mantegazza P
    Eur J Pharmacol; 1980 Jun; 64(2-3):133-41. PubMed ID: 6105081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
    Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice.
    Horowski R; Wachtel H
    Eur J Pharmacol; 1976 Apr; 36(2):373-83. PubMed ID: 945166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain.
    Kehr W
    Eur J Pharmacol; 1977 Feb; 41(3):261-73. PubMed ID: 837971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of an ergot derivative, lisuride, on the central dopaminergic system -- studies of behavioral pharmacology].
    Hara K; Ikoma Y; Oshino N
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):1-13. PubMed ID: 7173731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppressive effects of lisuride on the synthesis, release and metabolism of dopamine in rat brain].
    Azuma H; Iwai K; Sato K; Kikuta M; Liu HJ; Oshino N
    Nihon Yakurigaku Zasshi; 1982 Nov; 80(5):325-39. PubMed ID: 6131854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist actions of lisuride on dopamine neurons: electrophysiological evidence.
    Gessa GL
    J Neural Transm Suppl; 1988; 27():201-10. PubMed ID: 3165435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological evaluation of a partial agonist of dopamine receptors.
    Piercey MF; Hoffmann WE; Vogelsang GD; Travis M
    J Pharmacol Exp Ther; 1987 Oct; 243(1):391-6. PubMed ID: 3668865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?
    Gerber R; Barbaz BJ; Martin LL; Neale R; Williams M; Liebman JM
    Neurosci Lett; 1985 Sep; 60(2):207-13. PubMed ID: 2997677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lisuride and transdihydrolisuride: differences in action on central dopaminergic functions in dependence on the location and the state of receptors.
    Krejci I; Schuh J; Prágerová H; Dlabac A
    Pol J Pharmacol Pharm; 1985; 37(3):263-71. PubMed ID: 4070078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of subchronic lisuride to modify A10 dopamine autoreceptors' sensitivity.
    Mereu G; Hu XT; Wang RY; Westfall TC; Gessa GL
    Brain Res; 1987 Apr; 408(1-2):210-4. PubMed ID: 2885067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain.
    Jiang DH; Reches A; Wagner HR; Fahn S
    Neuropharmacology; 1984 Mar; 23(3):295-301. PubMed ID: 6539428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.
    Baggio G; Ferrari F
    Psychopharmacology (Berl); 1983; 80(1):38-42. PubMed ID: 6408668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.